Cargando…
Breast cancer recurrence after reconstruction: know thine enemy
Breast reconstruction proceeding cancer treatment carries risk, regardless of the type of surgery. From fat grafting, to flap placement, to implants, there is no guarantee that reconstruction will not stimulate breast cancer recurrence. Research in this field is clearly divided into two parts: scien...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021250/ https://www.ncbi.nlm.nih.gov/pubmed/29963246 http://dx.doi.org/10.18632/oncotarget.25602 |
_version_ | 1783335432648392704 |
---|---|
author | Brett, Elizabeth A. Aitzetmüller, Matthias M. Sauter, Matthias A. Huemer, Georg M. Machens, Hans-Günther Duscher, Dominik |
author_facet | Brett, Elizabeth A. Aitzetmüller, Matthias M. Sauter, Matthias A. Huemer, Georg M. Machens, Hans-Günther Duscher, Dominik |
author_sort | Brett, Elizabeth A. |
collection | PubMed |
description | Breast reconstruction proceeding cancer treatment carries risk, regardless of the type of surgery. From fat grafting, to flap placement, to implants, there is no guarantee that reconstruction will not stimulate breast cancer recurrence. Research in this field is clearly divided into two parts: scientific interventional studies and clinical retrospective evidence. The reconstructive procedure offers hypoxia, a wound microenvironment, bacterial load, adipose derived stem cells; agents shown experimentally to cause increased cancer cell activity. This is compelling scientific evidence which serves to bring uncertainty and fear to the reconstructive procedure. In the absence of clinical evidence, this laboratory literature landscape is now informing surgical choices. Curiously, clinical studies have not shown a clear link between breast cancer recurrence and reconstructive surgery. Where does that leave us? This review aims to analyze the science and the surgery, thereby understanding the oncological fear which accompanies breast cancer reconstruction. |
format | Online Article Text |
id | pubmed-6021250 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-60212502018-06-29 Breast cancer recurrence after reconstruction: know thine enemy Brett, Elizabeth A. Aitzetmüller, Matthias M. Sauter, Matthias A. Huemer, Georg M. Machens, Hans-Günther Duscher, Dominik Oncotarget Review Breast reconstruction proceeding cancer treatment carries risk, regardless of the type of surgery. From fat grafting, to flap placement, to implants, there is no guarantee that reconstruction will not stimulate breast cancer recurrence. Research in this field is clearly divided into two parts: scientific interventional studies and clinical retrospective evidence. The reconstructive procedure offers hypoxia, a wound microenvironment, bacterial load, adipose derived stem cells; agents shown experimentally to cause increased cancer cell activity. This is compelling scientific evidence which serves to bring uncertainty and fear to the reconstructive procedure. In the absence of clinical evidence, this laboratory literature landscape is now informing surgical choices. Curiously, clinical studies have not shown a clear link between breast cancer recurrence and reconstructive surgery. Where does that leave us? This review aims to analyze the science and the surgery, thereby understanding the oncological fear which accompanies breast cancer reconstruction. Impact Journals LLC 2018-06-12 /pmc/articles/PMC6021250/ /pubmed/29963246 http://dx.doi.org/10.18632/oncotarget.25602 Text en Copyright: © 2018 Brett et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Review Brett, Elizabeth A. Aitzetmüller, Matthias M. Sauter, Matthias A. Huemer, Georg M. Machens, Hans-Günther Duscher, Dominik Breast cancer recurrence after reconstruction: know thine enemy |
title | Breast cancer recurrence after reconstruction: know thine enemy |
title_full | Breast cancer recurrence after reconstruction: know thine enemy |
title_fullStr | Breast cancer recurrence after reconstruction: know thine enemy |
title_full_unstemmed | Breast cancer recurrence after reconstruction: know thine enemy |
title_short | Breast cancer recurrence after reconstruction: know thine enemy |
title_sort | breast cancer recurrence after reconstruction: know thine enemy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021250/ https://www.ncbi.nlm.nih.gov/pubmed/29963246 http://dx.doi.org/10.18632/oncotarget.25602 |
work_keys_str_mv | AT brettelizabetha breastcancerrecurrenceafterreconstructionknowthineenemy AT aitzetmullermatthiasm breastcancerrecurrenceafterreconstructionknowthineenemy AT sautermatthiasa breastcancerrecurrenceafterreconstructionknowthineenemy AT huemergeorgm breastcancerrecurrenceafterreconstructionknowthineenemy AT machenshansgunther breastcancerrecurrenceafterreconstructionknowthineenemy AT duscherdominik breastcancerrecurrenceafterreconstructionknowthineenemy |